BREAKING
BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit 2 minutes ago HPE Maintains $0.14 Quarterly Dividend With 2.61% Yield; Ex-Dividend Date March 24, 2026 1 hour ago Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates 2 hours ago Broadwind Energy Inc (BWEN) Reports Q4 Earnings 2 hours ago ATRenew Inc (RERE) Reports Q4 Earnings 2 hours ago Pangaea Logistics Solutions Ltd (PANL) Reports Q4 Earnings 3 hours ago SolarEdge (SEDG) Q4 Loss Narrows to $0.14/Share vs $0.24 Estimate, Stock Jumps 10% 3 hours ago Groupon Inc. (GRPN) Misses Q4 EPS Estimates 3 hours ago CRISPR Therapeutics (CRSP) Reports Wider Q4 Loss of $1.37/Share on Zero Revenue; Shares Plunge 10% 3 hours ago Cadre Holdings, Inc. (CDRE) Misses Q4 EPS Estimates 3 hours ago BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit 2 minutes ago HPE Maintains $0.14 Quarterly Dividend With 2.61% Yield; Ex-Dividend Date March 24, 2026 1 hour ago Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates 2 hours ago Broadwind Energy Inc (BWEN) Reports Q4 Earnings 2 hours ago ATRenew Inc (RERE) Reports Q4 Earnings 2 hours ago Pangaea Logistics Solutions Ltd (PANL) Reports Q4 Earnings 3 hours ago SolarEdge (SEDG) Q4 Loss Narrows to $0.14/Share vs $0.24 Estimate, Stock Jumps 10% 3 hours ago Groupon Inc. (GRPN) Misses Q4 EPS Estimates 3 hours ago CRISPR Therapeutics (CRSP) Reports Wider Q4 Loss of $1.37/Share on Zero Revenue; Shares Plunge 10% 3 hours ago Cadre Holdings, Inc. (CDRE) Misses Q4 EPS Estimates 3 hours ago
ADVERTISEMENT
PFE

Pfizer inc

$PFE NYSE May 4, 2021 DMH Q1 2021

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

PFE Coverage

News BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit Mar 11, 2026 Event Pfizer inc (PFE) Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis Mar 9, 2026 Event Pfizer inc (PFE) Sec Form 10K Feb 28, 2026 Event Pfizer inc (PFE) PADCEV + Keytruda Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer Feb 27, 2026 News Key highlights from Pfizer’s (PFE) Q4 2025 earnings results Feb 3, 2026 Transcript Pfizer inc (PFE) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Pfizer inc (PFE) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Key takeaways from Pfizer’s (PFE) Q3 2025 earnings report Nov 4, 2025